MIRA INFORM REPORT

 

 

Report Date :

15.09.2014              

 

IDENTIFICATION DETAILS

 

Name :

P.T. SINKONA INDONESIA LESTARI

 

 

Registered Office :

Jalan Raya Ciater Km.171, Subang, 41281, West Java

 

 

Country :

Indonesia

 

 

Date of Incorporation :

25.10.1986

 

 

Com. Reg. No.:

No. AHU-30998.AH.01.02.TH.2009

 

 

Legal Form :

Limited Liability Company

 

 

Line of Business :

Quinine Manufacturing

 

 

No. of Employees :

140

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory 

 

 

Payment Behaviour :

No complaints 

 

 

Litigation :

Clear

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 01, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Indonesia

B1

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

INDONESIA - ECONOMIC OVERVIEW

 

Indonesia, a vast polyglot nation, has grown strongly since 2010. During the global financial crisis, Indonesia outperformed its regional neighbors and joined China and India as the only G20 members posting growth. The government has promoted fiscally conservative policies, resulting in a debt-to-GDP ratio of less than 25% and historically low rates of inflation. Fitch and Moody's upgraded Indonesia's credit rating to investment grade in December 2011. Indonesia still struggles with poverty and unemployment, inadequate infrastructure, corruption, a complex regulatory environment, and unequal resource distribution among regions. The government also faces the challenges of quelling labor unrest and reducing fuel subsidies in the face of high oil prices

Source : CIA

 

 

 


BASIC SEARCH

 

Name of Company :

P.T. SINKONA INDONESIA LESTARI

 

A d d r e s s :

Head Office & Factory

Jalan Raya Ciater Km.171

Subang, 41281

West Java

Phones             - (62-260) 470918

Fax                   - (62-260) 470917

E-mail               - marketing@sinkonaindonesia.com

Website            - http://www.sinkona-indonesia.com

Land Area         - 24,600 sq. meters

Building Space  -   9,200 sq. meters

Region              - Industrial Zone

Status               - Owned

 

Branch

a.   Jalan Gegerkalong Hilir 143

      Sukarasa, Sukasari

Bandung 40152, West Java

Phones                   - (62-22) 2003103

Fax                         - (62-22) 2003104

E-mail                     - sinkona@bdg.centrin.net.id

Building Area           - 2 storey

Office Space            - 110 sq. meters

Region                    - Commercial

Status                     - Rent

b.   Jalan Dederuk No. 21

Bandung 40133, West Java

Phones                   - (62-22) 250 2852

Fax                         - (62-22) 253 1608

Building Area           - 2 storey

Office Space            - 140 sq. meters

Region                    - Commercial

Status                     - Rent

 

Date of Incorporation :

25 October 1986

 

Legal Form :

P.T. (Perseroan Terbatas) or Limited Liability Company

 

Company Reg. No. :

The Ministry of Law and Human Rights

No. AHU-30998.AH.01.02.TH.2009

Dated 7 July 2009

Company Status :

National Private Company

 

Permit by the Government Department :

The Department of Finance

NPWP No. 01.280.013.2-051.000

 

Related Companies :

a. P.T. KIMIA FARMA  (Pharmaceutical Industry and Investment Holding)

b. P.T. TRI USAHA BHAKTI (Investment Holding)

c. P.T. PERKEBUNAN NUSANTARA VIII (Plantation)

 

 

CAPITAL AND OWNERSHIP

 

Capital Structure :

Authorized Capital                            : Rp.  8,576,000,000.-

Issued Capital                                  : Rp.  8,576,000,000.-

Paid up Capital                                : Rp.  8,576,000,000.-

 

Shareholders/Owners :

a. P.T. KIMIA FARMA Tbk.                                  - Rp. 1,286,000,000.-

    Address : Jl. Veteran No. 9

                     Jakarta Pusat

b. P.T. PERKEBUNAN NUSANTARA VIII              - Rp. 5,574,000,000.-

    Address ; Jl. Metro Duta Niaga 17

                    Jakarta Selatan

c. P.T. TRI USAHA BHAKTI                                  - Rp. 1,716,000,000.-

    Address : Jl. Medan Meredeka Timur 7

                    Jakarta Pusat

 

 

BUSINESS ACTIVITIES

 

Lines of Business :

Quinine Manufacturing

 

Production Capacity :

Quinines                                              - 50 tons p.a.

 

Total Investment :

a. Equity Capital                              - Rp.   8.6 billion

b. Loan Capital                                - Rp.   5.0 billion

c. Total Investment                           - Rp. 13.6 billion

 

Started Operation :

1992

 

Brand Name :

None

 

Technical Assistance :

P.T. KIMIA FARMA Tbk

 

Number of Employee :

140 persons

 

Marketing Area :

Export      - 95%

Local       - 5%

 

Main Customer :

USA, South Korea, Taiwan, Philippines, Malaysia, Thailand, etc

 

Market Situation :

Competitive

 

Business Trend :

Growing

 

 

BANKER, AUDITOR & LITIGATION

 

B a n k e r s :

a.  P.T. Bank MANDIRI Tbk

      Bandung Branch

      West Java,

      Indonesia

b.   P.T. Bank Negara Indonesia Tbk

      Bandung Branch

      West Java

      Indonesia

 

Auditor :

Internal Auditor

 

Litigation :

No litigation record in our database

 

 

FINANCIAL FIGURE

 

Annual Sales (estimated) :

2011 – Rp. 121.0 billion

2012 – Rp. 134.0 billion

2013 – Rp. 146.0 billion

Net Profit (Loss) :

2011 – Rp.   9.7 billion

2012 – Rp. 10.7 billion

2013 – Rp. 11.9 billion

 

Payment Manner :

Average

 

Financial Comments :

Satisfactory

 

 

KEY EXECUTIVES

 

Board of Management :

President Director                            - Mrs. Ida Rahmi Kurniasih

Director                                           - Mr. Tri Bagus Santoso

 

Board of Commissioners :

President Commissioner                   - Mr. Irwan Abdulrahman Lubis

Commissioner                                 - a. Mr. Jisman Pantas Pandapotan Siagian

                                                        b. Mr. Hamdan Z. Nasution

 

Signatories :

President Director (Mrs. Ida Rahmi Kurniasih) or the Director (Mr. Tri Bagus Santoso) which must be approved by Board of Commissioners

 

 

CAPABILITIES

 

Management Capability :

Good

 

Business Morality :

Good

 

Credit Risk :

Below Average

 

Credit Recommendation :

Credit can be proceeded normally

 

Proposed Credit Limit :

Moderate Amount

 

 

OVERALL PERFORMANCE

 

P.T. SINKONA INDONESIA LESTARI (P.T. SIL) was established in October 1986 with an authorized capital of Rp. 23,410,000,000 issued capital of Rp. 6,206,000,000 and paid up capital of Rp. 2,358,280,000. The original founding shareholders are P.T. KIMIA FARMA, P.T. PERKEBUNAN NUSANTARA XII, P.T. PERKEBUNAN NUSANTARA XIII and P.T. TRI USAHA BHAKTI. The company notary deed has frequently been amendment. In August 1998 the authorized capital was reduced to Rp. 8,576,000,000 entirely issued and paid up. By the same time P.T. PERKEBUNAN NUSANTARA XII and P.T. PERKEBUNAN NUSANTARA XIII pulled out and replaced by P.T. PERKEBUNAN NUSANTARA VIII. The latest in December 2008 the board of director and board of commissioner has been changes (see profile of this report). The deed of amendment was made by Ms. Martinah Sumarnoo, SH., a public notary in Jakarta was approved by the Ministry of Law and Human Right in its Decision Letter No. AHU-30998.AH.01.02.TH.2009, dated July 07, 2009.

 

We observe the majority business stakes of P.T. SIL is controlled by P.T. PERKEBUNAN NUSANTARA VIII, a national private company engaged in quinine, tea and rubber plantation which the majority shares is controlled by the government.

 

P.T. SIL had been operating since 1992 in quinidine industry (pharmaceutical basic material being processed from quinine tree bark). P.T. SIL is a company that produces quinine salt and its derivatives for many industries, especially pharmaceuticals, beverages, and chemical industries. The cinchona alkaloids are a family of natural products which can be isolated from cinchona trees. There are about 40 different species of cinchona tree all of which are indigenous to the slopes of the Andes, however because of their commercial importance, several of these species are now widely cultivated in many tropical countries, including Indonesia. The most abundant of these alkaloids is quinine and this, along with quinidine, cinchonine and cinchonidine, can comprise up to 16% by mass of the tree bark. The types of products are Cinchona Alkaloids; Quinine Hydrochloride; Quinine Dihydrochloride; Quinine Sulphate; Quinine Base Anhydrous; Quinine Bisulphate; Quinidine Base; Quinidine Sulphate; Cinchonine and Cinchonidine.

 

The quinine plantation managed by P.T. PN VIII ranges 3.004,29 ha which consists of 13 plantations. The dried quinine bark is processed into SQ-7 or known as quinine salt which contains quinine sulphate, quinine bisulphate, and other materials. The production is managed by PT Sinkona Indonesia Lestari (P.T. SIL) as the subsidiary company of P.T. PN VIII. The product is exported to Europe, Canada, and America. The bark is usually harvested by beating the tree trunks and then removing the material that peels away. The tree can partially regenerate its bark over a few years, and several cycles of removing the bark and letting it grow back can be achieved before the trees have to be uprooted and replaced by new ones. P.T. SIL made a contribution on a national tree planting event at Banceuy customary forest in Sanca village, Ciater, Subang. The event was held on November 28th, 2013. P.T. SIL along with many companies in the south Subang area were planting 2000 fruit trees and 20000 perennial plants. The program was first initiated by P.T. Tirta Investama Plant and followed by other companies, including P.T. SIL, P.T. PN VIII, and P.T. Sari Ater Spa.

 

The products such as cinchonine, cinchonidine, quinine sulfate, quinine hydrochloride, quinine dihydrochloride and cinchona barks. Its plant is located at Ciater, Subang, West Java, producing quinine of 50 tons per year. The basic material (quinine tree bark) is supplied by P.T. PERKEBUNAN NUSANTARA VIII. Some 95% of the products is exported to the USA, South Korea, Taiwan, the Philippines, Malaysia, Thailand and the rest for local purpose. The marketing agents are; International Business Networks Pte. Ltd. (IBN); Arnold Suhr, Netherlands and Centerchem.  P.T. SIL is classified as a large sized company in the country dealing with quinidine industry of which the operation has been running smoothly and growing in the last five years up.

 

In overall we find the demand for quinidine had been rising by 6% to 7% within the last five years both local and international market in line with the growth of pharmaceutical industries and estimated it will be higher by 5% within the coming five years. While the competition is quite tight due a large number of similar companies operating in the country. Business position of P.T. SIL is not so critical for it has controlled a wide marketing network at home.

 

Until this time P.T. SIL has not been registered with Indonesian Stock Exchange, so that they had not obliged to announce their financial statement. The management of P.T. SIL is very reclusive towards outsiders and rejected to disclose its financial condition. We estimated that total sales turnover of the company in 2011 amounted to Rp. 121.0 billion rose to Rp. 134.0 billion in 2012 increased to Rp. 146.0 billion in 2013 and projected to go on rising by at least 6% in 2014. The operation in 2013 yielded an estimated net profit of at least Rp. 11.9 billion and the company has an estimated total networth of at least Rp. 31.0 billion. So far, we did not heard that the company having been black listed by the Central Bank (Bank Indonesia). The company usually pays its debts punctually to suppliers.

 

The management of P.T. SIL is led by Mrs. Ida Rahmi Kurniasih (49) a professional manager with experience in quinidine manufacturing and trading. She was graduated from Institute Teknologi Bandung, majoring in Pharmacy. She joined with P.T. Kimia Farma (Persero) Tbk since 2002, where by experience she developing many field of expertise like quality management system, production planning and control, warehousing, good manufacturing practice, food safety, and production of many pharmaceutical products including quinine. Before appointed as president director of P.T. Sinkona Indonesia Lestari in July 2013, her last position in P.T. Kimia Farma was Production Manager. She is member of Indonesian Pharmacist Association and ISPE.

 

The company's management is handled by professional staff in the above business. They have wide relations with private businessmen within and outside the country. So far, we did not hear that the management of the company being filed to the district court for detrimental cases or involved in any business malpractices. The company’s litigation record is clean and it has not registered with the black list of Bank of Indonesia. P.T. SINKONA INDONESIA LESTARI is sufficiently fairly good for business transaction.

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.84

UK Pound

1

Rs.98.72

Euro

1

Rs.78.64

 

INFORMATION DETAILS

 

Analysis Done by :

KAR

 

 

Report Prepared by :

PDT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.